FAQs

Consult Type (for Medicare Card Holders) Cost Medicare Rebate Out of Pocket Cost Initial Menopause Consult $300 $128.35 $171.65 Review Menopause Consult $160  $45.05 or $87.10 (dependant on length of consult) $114.95 or $72.90 (dependant on length of consult) Prices are for a 40 minute consult. Reach out to our team for a more detailed price breakdown.

For review consultations, it is best to consult with your regular menopause doctor for continuity of care. If they are unavailable, or if you would like to change doctor, when booking in your review appointment, you can change the filter to see all doctors' availabilities within the calendar.

Yes. You do not need to have stopped having periods to access care for perimenopause symptoms.

We’re working towards expanding Blossm to include people without a Medicare card in the near future. Our goal is to offer transparent, packaged pricing so you know what to expect, with no unexpected costs.Because menopause hormone therapy (MHT) requires ongoing clinical monitoring and general health checks, we’re carefully exploring how best to provide a safe, comprehensive service with clear and predictable costs for everyone.We appreciate your patience as we work towards making Blossm even more accessible.

Usually, no. For women aged 45 or over with typical symptoms and/or changes to their periods, perimenopause and menopause can generally be diagnosed based on your symptoms and menstrual history. Hormone levels naturally fluctuate considerably during perimenopause, which means a single blood test may not accurately reflect what is happening. Blood tests may be recommended in some circumstances - particularly if you are under 45, your symptoms are unusual, or your clinician needs to investigate another possible cause of your symptoms.

Blossm clinicians do not prescribe compounded menopausal hormone therapies or hormone troches. Where MHT is appropriate, clinicians can discuss evidence-based, regulated treatment options available in Australia. Compounded medications are individually prepared by a compounding pharmacy rather than being manufactured as standardised, approved products. While there may be circumstances where a compounded medicine is clinically appropriate, compounded hormone therapies are not routinely recommended for menopause care when suitable approved and regulated alternatives are available. Troches are a type of compounded medication that dissolve in the mouth and may contain hormones such as oestrogen, progesterone or testosterone. We do not prescribe hormone troches as part of our menopause service.

For many women, Menopausal Hormone Therapy (MHT) is an appropriate and effective treatment for menopausal symptoms. However, it is not suitable for everyone. Your clinician will assess your individual medical history, risk factors and treatment options before recommending MHT.

All consultations and data are kept 100% confidential.  Patient health information is stored in secure cloud storage and encrypted in the database. All data is stored in Australian data centres.